Company Filing History:
Years Active: 2025
Title: Neeti Ananthaswamy: Innovator in mRNA Vaccine Technology
Introduction
Neeti Ananthaswamy is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. Her work is crucial in the fight against infectious diseases, including the novel coronavirus.
Latest Patents
Neeti Ananthaswamy holds a patent for "Compositions and methods of mRNA vaccines against novel coronavirus infection." This patent describes a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The invention includes at least one non-naturally occurring amino acid mutation, with some embodiments derived from a delta variant. The patent also covers relevant polynucleotides, vectors, cells, compositions, kits, production methods, and methods of use. She has 1 patent to her name.
Career Highlights
Neeti Ananthaswamy is currently associated with Rnaimmune, Inc., where she continues to advance her research in mRNA technology. Her innovative approach has positioned her as a key player in the biotechnology sector.
Collaborations
Neeti has collaborated with notable colleagues, including Yong-Sik Bong and David Brown, to further enhance the development of mRNA vaccines.
Conclusion
Neeti Ananthaswamy's contributions to mRNA vaccine technology exemplify her dedication to advancing public health through innovation. Her work is vital in addressing global health challenges, particularly in the context of the COVID-19 pandemic.